XRHealth has received a patent to utilize approaches that incorporate biofeedback into its virtual reality/augmented reality therapy, it reports.
U.S. Patent No. 16/067,480, titled “A Therapy and Physical Training Device,” was issued on September 15, 2020.
These approaches are designed to enable VR/AR therapy to address patient pain based on biofeedback such us heart rate variability, EEG, galvanic skin response, and other critical responses while patients are using the VR/AR devices. Solutions that incorporate biofeedback allow patient treatment to be customized according to their unique needs and better inform clinicians on how patients are responding to therapy.
Incorporating Into Apple Watch
XRHealth plans to incorporate its VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat. XRHealth will use the output measurements of the Apple Watch to detect pain, which will modify VR/AR therapy treatment for patients based on the pain that they feel during the sessions, the company explains in a media release.
“The newly awarded patent reflects XRHealth’s commitment to creating the most sophisticated form of therapy that responds to patient physical needs in real-time. Virtual Reality therapy that incorporates biofeedback will enhance and personalize the patient experience and provide clinicians with critical insights.”
— Eran Orr, CEO of XRHealth
XRHealth created a virtual reality telehealth clinic that treats multiple conditions like anxiety & stress, cognitive impairment, pain management, Parkinson’s, and multiple sclerosis. XRHealth provides doctors with patient data that allows them to monitor and treat them in real-time, per the release.
[Source(s): XRHealth, PR Newswire]